New Delhi, May 29, 2019: Further to the disclosure (Ref: DIL:DIL/BSE/2019-20/F.No.: 49) regarding the major maintenance shutdown and de-bottlenecking programme at Dahej facility of the Company’s subsidiary, Fermenta Biotech Ltd., we wish to announce that the maintenance work as well as the de-bottlenecking programme is now complete. The plant had undergone a routine shutdown for repairs and maintenance along with a de-bottlenecking programme for capacity expansion.
With effect from 29th May 2019, the facility is back to operating at full capacities, which have increased by about 15% as a result of the de-bottlenecking programme.
Commenting on the development, Mr. Prashant Nagre, CEO, Fermenta Biotech Limited said :
“ The de-bottlenecking programme was a part of the capacity expansion measures that we are undertaking in order to cater to the increased demand for our products. We are happy to declare that this programme is now complete, and the Dahej facility has commenced production at its elevated capacity. Fermenta has always been committed to delivering quality products to its valued customers, and going forward as well, we will work towards our endeavour for excellence through continuous improvement in all our processes. ”
Corporate Comm India(CCI NewsWire)
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…